These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 37490236)
41. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans. Sheng WQ; Hashimoto H; Okamoto S; Ishida T; Meis-Kindblom JM; Kindblom LG; Hisaoka M J Pathol; 2001 May; 194(1):88-94. PubMed ID: 11329146 [TBL] [Abstract][Full Text] [Related]
42. [Pigmented fibrosarcomatous dermatofibrosarcoma protuberans (Bednar tumor). 3 case reports, analogy with the "conventional" type and review of the literature]. Bisceglia M; Vairo M; Calonje E; Fletcher CD Pathologica; 1997 Jun; 89(3):264-73. PubMed ID: 9380420 [TBL] [Abstract][Full Text] [Related]
43. Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP). Stacchiotti S; Pantaleo MA; Negri T; Astolfi A; Tazzari M; Dagrada GP; Urbini M; Indio V; Maestro R; Gronchi A; Fiore M; Dei Tos AP; Conca E; Palassini E; Vincenzi B; Grosso F; Pilotti S; Castelli C; Casali PG Clin Cancer Res; 2016 Feb; 22(4):837-46. PubMed ID: 26261104 [TBL] [Abstract][Full Text] [Related]
44. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Maki RG; Awan RA; Dixon RH; Jhanwar S; Antonescu CR Int J Cancer; 2002 Aug; 100(6):623-6. PubMed ID: 12209598 [TBL] [Abstract][Full Text] [Related]
45. An unusual presentation of dermatofibrosarcoma protuberans: A case of fibrosarcomatous dermatofibrosarcoma protuberans with pleomorphic angiectatic tumor-like changes. Yoshida KI; Fujii J; Honma K; Nakai S J Cutan Pathol; 2024 Aug; 51(8):609-613. PubMed ID: 38711216 [TBL] [Abstract][Full Text] [Related]
48. Dermatofibrosarcoma protuberans: Clinicopathological spectrum with emphasis on lymph node metastasis and fibrosarcomatous transformation. Dahiya S; Tomar R; Ahuja M; Mallya V; Mandal S; Khurana N; Rathi AK J Cancer Res Ther; 2022 Dec; 18(Supplement):S439-S443. PubMed ID: 36511000 [TBL] [Abstract][Full Text] [Related]
49. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation arising at the site of breast implant. Haghayeghi K; Dicomo JA; Edmonson D; Banet N Breast J; 2020 Sep; 26(9):1811-1813. PubMed ID: 32223026 [TBL] [Abstract][Full Text] [Related]
50. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas. Szollosi Z; Scholtz B; Egervari K; Nemes Z J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589 [TBL] [Abstract][Full Text] [Related]
51. Dermatofibrosarcoma protuberans: the diagnosis of high-grade fibrosarcomatous transformation. Choong P; Lindsay D; Khoo M; Saifuddin A Skeletal Radiol; 2021 Apr; 50(4):789-799. PubMed ID: 33001221 [TBL] [Abstract][Full Text] [Related]
52. A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change. Liang CA; Jambusaria-Pahlajani A; Karia PS; Elenitsas R; Zhang PD; Schmults CD J Am Acad Dermatol; 2014 Oct; 71(4):781-6. PubMed ID: 24755121 [TBL] [Abstract][Full Text] [Related]
53. The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans. Abbott JJ; Oliveira AM; Nascimento AG Am J Surg Pathol; 2006 Apr; 30(4):436-43. PubMed ID: 16625088 [TBL] [Abstract][Full Text] [Related]
54. Pediatric dermatofibrosarcoma protuberans: A clinicopathologic and genetic analysis of 66 cases in the largest institution in Southwest China. Zhang Z; Lu Y; Shi C; Chen M; He X; Zhang H Front Oncol; 2023; 13():1017154. PubMed ID: 36776313 [TBL] [Abstract][Full Text] [Related]
55. Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases. Mentzel T; Schärer L; Kazakov DV; Michal M Am J Dermatopathol; 2007 Oct; 29(5):443-8. PubMed ID: 17890911 [TBL] [Abstract][Full Text] [Related]
56. Fibrosarcomatous dermatofibrosarcoma protuberans: a rapidly growing 30 cm mass on the posterior scalp. Lerttiendamrong B; Annoppornchai P; Promniyom P Asian Biomed (Res Rev News); 2023 Aug; 17(4):200-205. PubMed ID: 37860677 [TBL] [Abstract][Full Text] [Related]
57. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Sjöblom T; Shimizu A; O'Brien KP; Pietras K; Dal Cin P; Buchdunger E; Dumanski JP; Ostman A; Heldin CH Cancer Res; 2001 Aug; 61(15):5778-83. PubMed ID: 11479215 [TBL] [Abstract][Full Text] [Related]
58. Prognostic impact of fibrosarcomatous transformation in dermatofibrosarcoma protuberans: a cohort study. Hoesly PM; Lowe GC; Lohse CM; Brewer JD; Lehman JS J Am Acad Dermatol; 2015 Mar; 72(3):419-25. PubMed ID: 25582537 [TBL] [Abstract][Full Text] [Related]
59. CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans. Goldblum JR Arch Pathol Lab Med; 1995 Mar; 119(3):238-41. PubMed ID: 7534057 [TBL] [Abstract][Full Text] [Related]